Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0312414 (Spotting)
 88 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Clinical experience with Eugynon as a contraceptive in 50 women, inc luding 40 lactating patients (540 cycles) and in the treatment of dysmenorrhea and cycle irregularities in 23 women (79 cycles) is reporte d. No pregnancy was observed in either group. In the contraceptive group, only slight changes in duration and volume of the menstrual flow were noted. Spotting was occasionally observed in the first few cycles; amenorrhea and breakthrough bleeding were not seen. No effects on lactation, liver function, or cardiovascular function, and other side effects were minimal. Results in patients with menstruation disorders were good: no menstrual complaints were reported and cycles were regulated. The authors compare Eugynon favorably with higher-dosed preparations.
Med Welt 1970 Oct 03
PMID:[Clinical studies in United Arabic Republic with SH 850 (Eugynon), a low dose oral contraceptive, with special reference to its effect on lactation]. 547 23